The SLC35A2 gene helps move galactose, a sugar building block, into the part of the cell that finishes many proteins and fats so they can work properly. This gene helps your body make these finished molecules correctly. If it does not work well, the body may not process these molecules normally, which can lead to seizures, developmental delay, low muscle tone, growth differences, and a rare condition called SLC35A2-congenital disorder of glycosylation.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or regulating processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mostly control when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
SLC35A2Gene function
What if the gene works
The SLC35A2 gene helps move galactose, a sugar building block, into the cell compartment where many proteins and fats are finished. This supports normal glycosylation, a sugar-tagging process that helps cells make working molecules.
Risk
What if the gene does not work
Variants in the SLC35A2 gene can cause a condition that often affects brain development, with seizures, developmental delay, and low muscle tone. Effects range from mild to severe, and more disruptive variants may lead to earlier or broader features.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss-of-function variant in the SLC35A2 gene, oral D-galactose can be part of care and may improve glycosylation, growth, development, or seizure control in some cases. Response varies, so this gene-specific treatment is usually tailored to symptoms and follow-up lab markers.
Conditions associated with SLC35A2
Gene function
What if the gene works
Many cells need the SLC35A2 gene to place a key sugar building block in the right spot at the right time. That step helps proteins and fats receive galactose, a sugar that becomes part of their finishing layer. Understanding what the SLC35A2 gene does in the body helps explain how cells keep their surfaces, signals, and shipping systems running smoothly.
The SLC35A2 gene moves a ready to use form of galactose into the Golgi (the cell’s packaging area). This supplies an essential sugar building block where many proteins and fats are finished.
Inside this cell compartment, the SLC35A2 gene supports glycosylation (adding small sugar units) to many proteins. These sugar additions help proteins fold, travel, and work in a steady way.
This gene also helps cells add galactose to certain fats in the cell membrane. These sugar coated fats support the cell surface and help cells communicate with their surroundings.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC35A2 gene can change the shape or stability of its transporter protein, so less UDP-galactose reaches the Golgi (the cell compartment that adds sugars to proteins and fats). This means how SLC35A2 variants affect sugar attachment in cells often depends on the specific change. Some variants leave partial activity, while more severe variants can greatly reduce or stop transport. Lower residual activity is often linked to earlier onset and broader effects in SLC35A2-related developmental and epilepsy conditions.
How variants are linked to conditions
Pathogenic variants in the SLC35A2 gene cause SLC35A2-related congenital disorder of glycosylation, a condition often diagnosed in children with developmental delay, low muscle tone, and seizures. Variants in the SLC35A2 gene are also linked to developmental and epileptic encephalopathy, and some mosaic variants have been found in people with focal epilepsy. These findings are well established in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences play a role. In other cases, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risk related to the SLC35A2 gene. In most families, SLC35A2-related conditions happen because of a new genetic change rather than something a parent did or did not do. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC35A2 variants
SLC35A2-related conditions usually follow an X-linked dominant inheritance pattern, which is the main SLC35A2 inheritance pattern described in clinical genetics. If a parent carries a disease-causing variant in the SLC35A2 gene, each child has a 50% chance of inheriting it, although many affected people have a new variant that was not inherited from either parent. Because the SLC35A2 gene is on the X chromosome, mothers can pass the variant to sons or daughters, while fathers can pass it to daughters but not to sons.
What does my SLC35A2 result mean for my family?
For families, an SLC35A2 result is usually considered in an X-linked pattern, so close relatives may also carry the same change and may want to discuss family testing. The exact effects can vary a lot, even within one family. Many reported cases happen because of a new gene change, so a parent may not have the same result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC35A2 gene, a lab studies DNA from blood, saliva, or sometimes skin. SLC35A2 genetic testing is usually done as part of a broader gene panel or exome test. Results may show a variant linked to the condition, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the SLC35A2 gene may be worth considering when a child has unexplained seizures, developmental delay, low muscle tone, or other signs of a rare condition present from birth. It can also help clarify a diagnosis after abnormal sugar-processing tests or brain findings. Decisions about testing are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it can explain varies with the condition and the kind of variant present. Over time, the way the body functions is also shaped by factors like lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when viewed together with other parts of care. In other situations, a genetic result can give a definite answer. In areas like medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body absorbs, breaks down, or uses a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By studying the links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence how the body handles a drug and how strong its effects may be. This information can support treatment decisions that are both better informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC35A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so if you have concerns about side effects, a new prescription, or a treatment change, talk with your doctor or pharmacist.